karyopherin β3 Inhibitors

Karyopherin β3 inhibitors, as discussed here, predominantly act indirectly. Karyopherin β3 (Transportin-3) is integral to the nuclear import of various proteins and RNA-protein complexes, a process essential for normal cellular function and signaling. The inhibitors listed above do not target Karyopherin β3 directly but affect it through various cellular processes and pathways. Compounds like Importazole and Ivermectin, which interfere with nuclear transport mechanisms, can indirectly impact Karyopherin β3's function. Importazole, known for its inhibitory action on importins, suggests a potential overlap or interplay in the nuclear import pathways that could influence Karyopherin β3 activity. Similarly, Ivermectin's disruption of nuclear transport mechanisms might also affect processes mediated by Karyopherin β3.

Other inhibitors like Selinexor and Leptomycin B, which target nuclear export processes, could indirectly influence the nuclear import dynamics where Karyopherin β3 is involved. By altering the balance of nuclear-cytoplasmic transport, these inhibitors might impact Karyopherin β3's function. Additionally, compounds affecting broader cellular functions, such as Sirolimus (Rapamycin), Brefeldin A, and Colchicine, might also indirectly influence Karyopherin β3. These inhibitors, by modulating signaling pathways, vesicular trafficking, or cytoskeletal dynamics, can impact the cellular environment and processes in which Karyopherin β3 operates.